AIM ImmunoTech Inc.
AIM
$0.23
$0.00-0.44%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 95.00K | 94.00K | 88.00K | 112.00K | 121.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 95.00K | 94.00K | 88.00K | 112.00K | 121.00K |
| Cost of Revenue | 117.00K | 122.00K | 128.00K | 95.00K | 35.00K |
| Gross Profit | -22.00K | -28.00K | -40.00K | 17.00K | 86.00K |
| SG&A Expenses | 8.54M | 7.08M | 7.87M | 10.26M | 11.54M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.23M | 10.37M | 11.75M | 14.68M | 16.73M |
| Operating Income | -11.14M | -10.27M | -11.66M | -14.57M | -16.61M |
| Income Before Tax | -14.27M | -13.28M | -13.96M | -15.75M | -16.17M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -14.27 | -13.28 | -13.96 | -15.75 | -16.17 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -14.27M | -13.28M | -13.96M | -15.75M | -16.17M |
| EBIT | -11.14M | -10.27M | -11.66M | -14.57M | -16.61M |
| EBITDA | -10.47M | -9.81M | -11.19M | -14.07M | -16.11M |
| EPS Basic | -3.93 | -7.39 | -11.96 | -19.86 | -24.70 |
| Normalized Basic EPS | -3.36 | -5.52 | -8.40 | -13.15 | -15.57 |
| EPS Diluted | -3.93 | -7.39 | -11.96 | -19.86 | -24.70 |
| Normalized Diluted EPS | -3.36 | -5.52 | -8.40 | -13.15 | -15.57 |
| Average Basic Shares Outstanding | 26.45M | 10.09M | 6.44M | 4.20M | 2.68M |
| Average Diluted Shares Outstanding | 26.45M | 10.09M | 6.44M | 4.20M | 2.68M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |